Publications: group A Streptococcus

On This Page

2000 to Present:

  • Centers for Disease Control and Prevention. 2019. Active Bacterial Core Surveillance Report, Emerging Infections Program Network, Group A Streptococcus, 2019 pdf icon[1 page].
  • Fay K, Onukwube J, Chochua S, et al. Patterns of antibiotic nonsusceptibility among invasive group A Streptococcus infections-United States, 2006-2017 [published online ahead of print, 2021 Jun 25]. Clin Infect Dis. 2021;ciab575.
  • Nanduri SA, Onukwube J, Apostol M, et al. Challenges in Surveillance for Streptococcal Toxic Shock Syndrome: Active Bacterial Core Surveillance, United States, 2014-2017 [published online ahead of print, 2021 May 7]. Public Health Rep. 2021;333549211013460.
  • Velusamy S, Jordak K, Kupor M, Chochua S, McGee L, Beall B. Sequential Quadriplex Real-Time PCR for Identifying 20 Common emm Types of Group A StreptococcusJ Clin Microbiol. 2020;59(1):e01764-20. Published 2020 Dec 17.
  • Li Y, Rivers J, Mathis S, et al. Genomic Surveillance of Streptococcus pyogenes Strains Causing Invasive Disease, United States, 2016-2017. Front Microbiol. 2020;11:1547. Published 2020 Jul 24.
  • Valenciano SJ, Onukwube J, Spiller MW, et al. Invasive Group A Streptococcal Infections Among People Who Inject Drugs and People Experiencing Homelessness in the United States, 2010-2017 [published online ahead of print, 2020 Jun 17]. Clin Infect Dis. 2020;ciaa787.
  • Centers for Disease Control and Prevention. 2018. Active Bacterial Core Surveillance Report, Emerging Infections Program Network, Group A Streptococcus, 2018.
  • Link-Gelles R, Toews KA, Schaffner W, et al. Characteristics of Intracranial Group A Streptococcal Infections in US Children, 1997-2014. J Pediatric Infect Dis Soc. 2020;9(1):30-35.
  • Chochua S, Rivers J, Mathis S, et al. Emergent Invasive Group A Streptococcus dysgalactiae subsp. equisimilis, United States, 2015-2018. Emerg Infect Dis. 2019;25(8):1543-1547.
  • Centers for Disease Control and Prevention. 2017. Active Bacterial Core Surveillance Report, Emerging Infections Program Network, Group A Streptococcus, 2017.
  • Chochua S, Metcalf BJ, Li Z, et al. Population and whole genome sequence based characterization of invasive group A streptococci recovered in the United States during 2015external icon. mBio. 2017;8(5):e01422–17
  • Smeesters PR, Laho D, Beall B, Steer AC, Van Beneden CA. Seasonal, Geographic, and Temporal Trends of emm Clusters Associated with Invasive Group A Streptococcal Infections in US Multistate Surveillance.  Clin Infect Dis. 2017 Feb 10. doi: 10.1093/cid/ciw807.
  • Centers for Disease Control and Prevention. Active Bacterial Core Surveillance Report, Emerging Infections Program Network, Group A Streptococcus, 2016 pdf icon[1 page].
  • Lindegren ML, McCormack L, Barnes B, Mitchel E, Jones S, Schaffner W.  Assessment of Administrative Medical Claims Data for Public Health Surveillance of Invasive Group A Streptococcal Necrotizing Faciitis in Tennessee.  Public Health Rep. 2016 Jul-Aug; 131(4):560-5.
  • Nelson GE, Pondo T, Toews KA, Farley MM, Lindegren ML, Lynfield R, Aragon D, Zansky SM, Watt JP, Cieslak PR, Angeles K, Harrison LH, Petit S, Beall B, Van Beneden CA. Epidemiology of Invasive Group A Streptococcal Infections in the United States 2005-2012. Clin Infectious Dis 2016, doi: 10.1093/cid/ciw248
  • Centers for Disease Control and Prevention. Active Bacterial Core Surveillance Report, Emerging Infections Program Network, Group A Streptococcus, 2015 pdf icon[1 page].
  • Langley G, Hao Y, Pondo T, et al. The Impact of Obesity and Diabetes on the Risk of Disease and Death due to Invasive Group A Streptococcus Infections in Adults. Clin Infect Dis. (2015); doi: 10.1093/cid/civ1032
  • Zhu L, Olsen RJ, Nasser W, et al. A molecular trigger for intercontinental epidemics of group A Streptococcus. J Clin Invest. 2015;125(9):3545–3559. doi:10.1172/JCI82478.
  • Centers for Disease Control and Prevention. Active Bacterial Core Surveillance Report, Emerging Infections Program Network, Group A Streptococcus, 2014 pdf icon[1 page].
  • Nasser W, Beres SB, Olsen RJ, et al. Evolutionary pathway to increased virulence and epidemic group A Streptococcus disease derived from 3,615 genome sequences. Proc Natl Acad Sci 2014.14;111(17):E1768-76. Epub 2014 Apr 14.
  • Centers for Disease Control and Prevention. Active Bacterial Core Surveillance Report, Emerging Infections Program Network, Group A Streptococcus, 2013 pdf icon[1 page].
  • Dooling KL, Crist MB, Nguyen DB, et al. Investigation of a prolonged group a streptococcal outbreak among residents of a skilled nursing facility, Georgia, 2009-2012external icon. Clin Infect Dis. 2013 Dec;57(11):1562-7. Epub 2013 Sep 9.
  • Centers for Disease Control and Prevention. Active Bacterial Core Surveillance Report, Emerging Infections Program Network, Group A Streptococcus, 2012 pdf icon[1 page].
  • Fittipaldi N, Olsen RJ, Beres SB, Van Beneden C, Musser JM. Genomic analysis of emm59 group A Streptococcus invasive strains, United States. Emerg Infect Dis 2012;18(4):650-2.
  • Olsen RJ, Laucirica DR, Watkins ME, et al. Polymorphisms in Regulator of Protease B (RopB) Alter Disease Phenotype and Strain Virulence of Serotype M3 Group A Streptococcus. J Infect Dis 2012; 205(11):1719-29.
  • Centers for Disease Control and Prevention. Active Bacterial Core Surveillance Report, Emerging Infections Program Network, Group A Streptococcus, 2011 pdf icon[1 page].
  • Angeles K, Nichols M, Bareta J, Baumbach J. Invasive Group A Streptococcal: New Mexico, 2004-2009. New Mexico Epidemiology. 2010; 2010(9).
  • Centers for Disease Control and Prevention. Active Bacterial Core Surveillance Report, Emerging Infections Program Network, Group A Streptococcus, 2010 pdf icon[1 page].
  • Ahmad Y, Gertz RE, Jr., Li Z, et al. Genetic relationships deduced from emm and multilocus sequence typing of invasive Streptococcus dysgalactiae subsp. equisimilis and S. canis recovered from isolates collected in the United States. J Clin Microbiol 2009;47 (7): 2046-54.
  • Broyles LN, Van Beneden C, Beall B, et al. Population-based study of invasive disease caused by beta-hemolytic streptococci of groups other than A and B. Clin Infect Dis 2009;48(6):706-12.
  • Centers for Disease Control and Prevention. Active Bacterial Core Surveillance Report, Emerging Infections Program Network, Group A Streptococcus, 2009 pdf icon[1 page].
  • Lauth X, von Köckritz-Blickwede M, McNamara CW, et al. M1 protein allows group A Streptococcal survival in phagocyte extracellular traps through Cathelicidin inhibition. J Innate Immun 2009; 1:202-14.
  • Steer AC, Law I, Matatolu L, Beall BW, Carapetis JR. Global emm type distribution of group A streptococci: systematic review and implications for vaccine development.external icon Lancet Infect Dis 2009;10:611-6.
  • Centers for Disease Control and Prevention. Group A streptococcal M protein gene database. Downloadable FTP databases; updated 12/18/08.
  • Centers for Disease Control and Prevention. Active Bacterial Core Surveillance Report, Emerging Infections Program Network, Group A Streptococcus, 2008 pdf icon[1 page].
  • Rainbow J, Jewell B, Danilla RN, et al. Invasive Group A Streptococcal Disease in Nursing Homes, Minnesota, 1995-2006. Emerg Infect Dis 2008;14(5):772-77.
  • Woodbury RL, Klammer KA, Xiong Y, et al. Plasmid-borne erm(t) from invasive, macrolide-resistant Streptococcus pyogenes Strains. Antimicrob Agents Chemother 2008;52(3):1140-3.
  • Centers for Disease Control and Prevention. Active Bacterial Core Surveillance Report, Emerging Infections Program Network, Group A Streptococcus, 2007 pdf icon[1 page].
  • O’Loughlin RE, Roberson A, Cieslak PR, et al. The epidemiology of invasive group A streptococcal infection and potential vaccine implications: United States, 2000-2004. Clin Infect Dis 2007; 45:853-61.
  • Thigpen MC, Richards CL, Lynfield R, et al. Invasive group A streptococcal infection in older adults in long-term care facilities and the community, United States, 1998-2003. Emerg Infect Dis 2007;13:1852-59.
  • Arnold KE, Schweitzer JL, Wallace B, et al. Tightly clustered outbreak of group A streptococcal disease at a long-term care facility.external icon Infect Control Hosp Epidemiol 2006;12:1377-84.
  • Centers for Disease Control and Prevention. Active Bacterial Core Surveillance Report, Emerging Infections Program Network, Group A Streptococcus, 2006 pdf icon[1 page].
  • Johnson DR, Kaplan EL, VanGheem A, Facklam RR, Beall B. Characterization of group A streptococci (Streptococcus pyogenes): correlation of M-protein and emm-gene type with T-protein agglutination pattern and serum opacity factor. J Med Microbiol. 2006;55:157-64.
  • Persson J, Beall B, Linse S, Lindhal G. Extreme sequence divergence but conserved ligand-binding specificity in Streptococcus pyogenes M protein. PLoS Pathog 2006; 2(5):e47.
  • Pletz MW, McGee L, Van Beneden CA, et al. The emergence of fluoroquinolone-resistance in invasive Streptococcus pyogenes isolates due to spontaneous mutation and horizontal gene transfer. Antimicrob Agents Chemother. 2006;50:943-8.
  • Sakota V, Fry AM, Lietman TM, Facklam RR, Li Z, Beall B. Genetically diverse group A streptococci from children in far-western Nepal share high genetic relatedness with isolates from other countries. J Clin Microbiol 2006;44(6):2160-6.
  • Centers for Disease Control and Prevention. Active Bacterial Core Surveillance Report, Emerging Infections Program Network, Group A Streptococcus, 2005 pdf icon[1 page].
  • Dale JB, Penfound T, Chiang EY, Long V, Shulman ST, Beall B. Multivalent group A streptococcal vaccine elicits bactericidal antibodies against variant M subtypes. Clin Diagn Lab Immunol. 2005;12:833-6.
  • Factor SH, Levine OS, Harrison LH, et al. Risk factors for pediatric invasive group A streptococcal disease. Emerg Infect Dis 2005;11(7):1062-6.
  • Centers for Disease Control and Prevention. Active Bacterial Core Surveillance Report, Emerging Infections Program Network, Group A Streptococcus, 2004 pdf icon[1 page].
  • Shulman ST, Tanz RR, Kabat K, et al. Group A streptococcal pharyngitis serotype surveillance in North America, 2000-2002. Clin Infect Dis 2004;39:325-32.
  • Centers for Disease Control and Prevention. Active Bacterial Core Surveillance Report, Emerging Infections Program Network, Group A Streptococcus, 2003 pdf icon[1 page].
  • Espinosa LE, Li Z, Rodriguez RS, Facklam R, Beall B. M-protein gene type distribution within group A streptococcal clinical isolates recovered in Mexico during years 1991-2000: Overlap with type distribution within the United States. J. Clin Microbiol 2003;41:373-8.
  • Factor SH, Levine OS, Schwartz B, et al. Invasive group A streptococcal disease: risk factors for adults. Emerg Infect Dis 2003;9(8):970-7.
  • Igwe EI, Shewmaker PL, Facklam RR, Farley MM, Van Beneden C, Beall B. Identification of superantigen genes speM, ssa, and smeZ in invasive strains of beta-hemolytic group C and G streptococci recovered from humans. FEMS Microbiol Lett 2003;229(2):259-64.
  • Jeng A, Sakota V, Li Z, Datta V, Beall B, Nizet V. Molecular genetic analysis of a group A Streptococcus operon encoding serum opacity factor and a novel fibronectin-binding protein, SfbX. J Bacteriol 2003;185(4):1208-17.
  • Li Z, Sakota V, Jackson D, Franklin AR, Beall B; Active Bacterial Core Surveillance/Emerging Infections Program Network.  Array of M protein gene subtypes in 1064 recent invasive group A streptococcus isolates recovered from the active bacterial core surveillance. J Infect Dis 2003;188(10):1587-92.
  • Passaro DJ, Smith DS, Hett EC, et al. Invasive Group A Streptococcal Infections in the San Francisco Bay Area, 1989-1999. Epidemiol Infect 2003;129(3): 471-8.
  • Robinson KA, Rothrock G, Phan Q, et al. Active Bacterial Core Surveillance/Emerging Infections Program Network. Risk for severe group A streptococcal disease among patients’ household contacts. Emerg Infect Dis 2003;9(4):443-7.
  • Centers for Disease Control and Prevention. Active Bacterial Core Surveillance Report, Emerging Infections Program Network, Group A Streptococcus, 2002 pdf icon[1 page].
  • Chuang I, Van Beneden C, Beall B, Schuchat A and the ABCs/EIP Network. Population-based surveillance for postpartum invasive group A streptococcal infections, 1995-2000. Clin Infect Dis 2002;35:665-70.
  • Espinosa LE, Li Z, Rodriguez RS, Facklam R, Beall B. M protein gene type distribution within group A streptococcal clinical isolates recovered in Mexico during years 1991-2000: Overlap with type distribution within the United States. J Clin Microbiol 2002;41:373-8.
  • Facklam RF, Martin DR, Lovgren M, et al. Extension of the classification for group A streptococci by addition of 22 new M protein gene sequence types from clinical isolates: emm103 to emm104. Clin Infect Dis 2002;34:28-38.
  • Hu MC, Walls MA, Stroop S, Reddish M, Beall B, and Dale JB. Immunogenicity of a 26-valent group A streptococcal vaccine. Infect Immun 2002;70:2171-77.
  • O’Brien K, Beall B, Barrett NL, et al. Epidemiology of invasive group A streptococcus disease in the United States, 1995-1999. Clin Infect Dis 2002;35:268-76.
  • The Prevention of Invasive Group A Streptococcal Infections Workshop Participants. Prevention of invasive group A streptococcal disease among household contacts of case-patients and among postpartum and post-surgical patients: Recommendations from the Centers for Disease Control and Prevention. Clin Infect Dis 2002;35:950-9.
  • Centers for Disease Control and Prevention. Active Bacterial Core Surveillance Report, Emerging Infections Program Network, Group A Streptococcus, 2001 pdf icon[1 page].
  • Stefonek KR, Maerz LL, Nielson MP, Besser RE, Cieslak PR. Group A streptococcal puerperal sepsis preceded by positive surveillance cultures. Obstet Gynecol 2001;98:846-48.
  • Beall B, Gherardi G, Lovgren M, Forwick B, Facklam R, and Tyrrell G. emm and sof gene sequence variation in relation to serological typing of opacity factor positive group A streptococci. Microbiol 2000;146:1195-1209.
  • Centers for Disease Control and Prevention. Active Bacterial Core Surveillance Report, Emerging Infections Program Network, Group A Streptococcus, 2000 pdf icon[1 page].
  • Nizet V, Beall B, Bast DJ, et al. Genetic locus for streptolysin S production by group A streptococcus. Infect Immun 2000;68(7):4245-54.

 Top of Page

 1995-1999:

  • Centers for Disease Control and Prevention. Active Bacterial Core Surveillance Report, Emerging Infections Program Network, Group A Streptococcus, 1999 pdf icon[1 page].
  • Facklam R, Beall B, Efstratiou A, Fischetti V, Johnson D, Kaplan E, Kriz P, Lovgren M, Martin D, Schwartz B, Totolian A, Bessen D, Hollingshead S, Rubin F, Scott J, Tyrrell, G. Demonstration of emm typing and validation of provisional M types for group A streptococci. Emerg Infect Dis 1999;5:247-53.
  • Hoe NP, Nakashima K, Lukomski S, Grigsby D, Liu M, Kordari P, Dou SJ, Pan X, Vuopio-Varkila J, Salmenlinna S, McGeer A, Low DE, Schwartz B, Schuchat A, Naidich S, DeLorenzo D Yun-Xin F, Musser JM. Rapid selection of structural variants of group A streptococcus complement-inhibiting protein sustains and enlarges serotype M1 epidemic waves. Nat Med 1999;5:924-9.
  • York MK, Gibbs L, Perdreau-Remington F, Brooks GF. Characterization of antimicrobial resistance in Streptococcus pyogenes isolates from the San Francisco Bay area of Northern California. J Clin Microbiol 1999;37(6):1727-31.
  • Beall B, Facklam R, Elliott JA, Franklin AR, Hoenes T, Jackson D, Laclaire L, Thompson T, Viswanathan R. Streptococcal emm types associated with T agglutination patterns and the use of conserved emm gene restriction fragment patterns for sub-typing group A streptococci. J Med Microbiol 1998;47:893-8.
  • Centers for Disease Control and Prevention. Active Bacterial Core Surveillance Report, Emerging Infections Program Network, Group A Streptococcus, 1998 pdf icon[1 page].
  • The Working Group on Prevention of Invasive Group A Streptococcal Infections. Prevention of invasive group A streptococcal disease among household contacts of case-patients. JAMA 1998;279:1206-10.
  • Zurawski CA, Bardsley M, Beall B, Elliott JA, Facklam RR, Schwartz B, Farley M. Invasive group A streptococcal disease in metropolitan Atlanta: a population-based assessment. Clin Infect Dis 1998;27:150-7.
  • Beall B, Facklam R, Hoenes T, Schwartz B. A survey of emm gene sequences from systemic Streptococcus pyogenes infection isolates collected in San Francisco, California; Atlanta, Georgia; and Connecticut in 1994 and 1995. J Clin Microbiol 1997;35:1231-5.
  • Centers for Disease Control and Prevention. Active Bacterial Core Surveillance Report, Emerging Infections Program Network, Group A Streptococcus, 1997 pdf icon[1 page].
  • Fiorentino TR, Beall B, Mshar P, Bessen DE. A genetic-based evaluation of principal tissue reservoir for group A streptococci isolated from normally sterile sites. J Infect Dis 1997;176:177-82.
  • Beall B, Facklam R, Thompson T. Sequencing emm-specific PCR products for routine and accurate typing of group A streptococci. J Clin Microbiol 1996;34:953-58.

 Top of Page